- Home
- MREO vs HRZN Comparison
MREO vs HRZN Comparison
Compare MREO & HRZN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MREO
- HRZN
- Stock Information
- Founded
- MREO 2015
- HRZN 2008
- Country
- MREO United Kingdom
- HRZN United States
- Employees
- MREO N/A
- HRZN N/A
- Industry
- MREO Biotechnology: Pharmaceutical Preparations
- HRZN Finance/Investors Services
- Sector
- MREO Health Care
- HRZN Finance
- Exchange
- MREO Nasdaq
- HRZN Nasdaq
- Market Cap
- MREO 311.8M
- HRZN 275.7M
- IPO Year
- MREO N/A
- HRZN 2010
- Fundamental
- Price
- MREO $1.84
- HRZN $6.69
- Analyst Decision
- MREO Strong Buy
- HRZN Hold
- Analyst Count
- MREO 5
- HRZN 4
- Target Price
- MREO $7.40
- HRZN $7.38
- AVG Volume (30 Days)
- MREO 1.6M
- HRZN 749.8K
- Earning Date
- MREO 11-10-2025
- HRZN 10-28-2025
- Dividend Yield
- MREO N/A
- HRZN 19.72%
- EPS Growth
- MREO N/A
- HRZN N/A
- EPS
- MREO N/A
- HRZN N/A
- Revenue
- MREO $500,000.00
- HRZN $98,899,000.00
- Revenue This Year
- MREO N/A
- HRZN $0.85
- Revenue Next Year
- MREO $72.16
- HRZN $9.80
- P/E Ratio
- MREO N/A
- HRZN N/A
- Revenue Growth
- MREO N/A
- HRZN N/A
- 52 Week Low
- MREO $1.47
- HRZN $5.71
- 52 Week High
- MREO $4.29
- HRZN $9.99
- Technical
- Relative Strength Index (RSI)
- MREO 45.03
- HRZN 60.40
- Support Level
- MREO $1.65
- HRZN $6.55
- Resistance Level
- MREO $1.93
- HRZN $6.71
- Average True Range (ATR)
- MREO 0.12
- HRZN 0.16
- MACD
- MREO -0.02
- HRZN 0.06
- Stochastic Oscillator
- MREO 36.00
- HRZN 82.22
About MREO Mereo BioPharma Group plc
Mereo BioPharma Group PLC is a United Kingdom (U.K.) based biopharmaceutical company focused on the development of therapeutics for rare diseases. The company has developed a portfolio of late-stage clinical product candidates, and its two rare disease product candidates are setrusumab for the treatment of osteogenesis imperfecta (OI) and alvelestat primarily for the treatment of severe alpha-1 antitrypsin deficiency-associated lung disease (AATD-LD).
About HRZN Horizon Technology Finance Corporation
Horizon Technology Finance Corp is a specialty finance company. Its investment objective is to maximize its investment portfolio's total return by generating current income from the debt investments it makes and capital appreciation from the warrants it receives when making such debt investments. It lends to and invests in development-stage companies in the technology, life science, healthcare information and services, and sustainability industries.